Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2175
Publisher
MDPI AG
Online
2020-08-06
DOI
10.3390/cancers12082175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unraveling the Signaling Balance of Activation and Exhaustion of CAR T Cells
- (2020) Irene Scarfò et al. CANCER CELL
- Prospects and Challenges for Use of CAR T Cell Therapies in Solid Tumors
- (2020) Sneha Ramakrishna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells
- (2020) Manish Malviya et al. JOURNAL OF AUTOIMMUNITY
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- Engineering primary T cells with chimeric antigen receptors for rewired responses to soluble ligands
- (2020) ZeNan L. Chang et al. Nature Protocols
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
- (2020) Alyssa Sheih et al. Nature Communications
- Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments
- (2020) Yushu Joy Xie et al. Cancer Immunology Research
- Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy
- (2020) Xianwu Wang et al. ACS Central Science
- Engineering light-controllable CAR T cells for cancer immunotherapy
- (2020) Ziliang Huang et al. Science Advances
- A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
- (2020) Rebecca Epperly et al. Frontiers in Oncology
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
- (2020) Amy J. Petty et al. Cancers
- T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field
- (2019) Laura Sanz-Ortega et al. JOURNAL OF NANOBIOTECHNOLOGY
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
- (2019) Jessica B. Foster et al. MOLECULAR THERAPY
- CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
- (2019) Nicholas F. Kuhn et al. CANCER CELL
- In Vivo Generation of Gut-Homing Regulatory T Cells for the Suppression of Colitis
- (2019) Yi Xu et al. JOURNAL OF IMMUNOLOGY
- Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
- (2019) Yushu Joy Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- (2019) Kalijn F. Bol et al. Journal for ImmunoTherapy of Cancer
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- B cells engineered to express pathogen-specific antibodies protect against infection
- (2019) Howell F. Moffett et al. Science Immunology
- In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
- (2019) Luciano Castiello et al. Frontiers in Immunology
- Enhanced alleviation of aGVHD by TGF‐β1‐modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells
- (2019) Ran Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
- (2019) Stephen J. Bagley et al. PHARMACOLOGY & THERAPEUTICS
- Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
- (2019) F. Zhang et al. Nature Communications
- Remodeling of Cellular Surfaces via Fast Disulfide–Thiol Exchange To Regulate Cell Behaviors
- (2019) Lianghua He et al. ACS Applied Materials & Interfaces
- Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours
- (2019) Michael E. Coon et al. Nature Biomedical Engineering
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
- (2018) Jang Hwan Cho et al. CELL
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Engineering the Surface of Therapeutic “Living” Cells
- (2018) Jooyeon Park et al. CHEMICAL REVIEWS
- T cell senescence and CAR-T cell exhaustion in hematological malignancies
- (2018) Dimitri Kasakovski et al. Journal of Hematology & Oncology
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Driving T-cell immunotherapy to solid tumors
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- Rewiring T-cell responses to soluble factors with chimeric antigen receptors
- (2018) ZeNan L Chang et al. Nature Chemical Biology
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
- (2018) Jonathan T. Sockolosky et al. SCIENCE
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection
- (2018) Danping Hong et al. Stem Cell Research & Therapy
- Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
- (2018) Raul Vizcardo et al. Cell Reports
- CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
- (2018) Natnaree Siriwon et al. Cancer Immunology Research
- Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
- (2018) Patty Sachamitr et al. Frontiers in Immunology
- Current Status of Gene Engineering Cell Therapeutics
- (2018) Aurore Saudemont et al. Frontiers in Immunology
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
- (2018) Marco Ruella et al. NATURE MEDICINE
- Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
- (2018) Matthew J. Johnson et al. Scientific Reports
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
- (2018) Atsutaka Minagawa et al. Cell Stem Cell
- Programmed cell death protein 1 activation preferentially inhibits CD28.CAR–T cells
- (2018) Sergey N. Zolov et al. CYTOTHERAPY
- Treg cells—the next frontier of cell therapy
- (2018) Jeffrey A. Bluestone et al. SCIENCE
- Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen Receptor
- (2018) Ryosuke Uchibori et al. Molecular Therapy-Oncolytics
- CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes
- (2017) Long Shi et al. GENE
- Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy
- (2017) Kara W. Moyes et al. HUMAN GENE THERAPY
- Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
- (2017) Tyrel T. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
- (2017) M D Mathias et al. LEUKEMIA
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
- (2017) Elizabeth L. Siegler et al. MOLECULAR THERAPY
- Masked Chimeric Antigen Receptor for Tumor-Specific Activation
- (2017) Xiaolu Han et al. MOLECULAR THERAPY
- Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies
- (2017) Amin Reza Nikpoor et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
- (2017) H. F. Moffett et al. Nature Communications
- An oxygen sensitive self-decision making engineered CAR T-cell
- (2017) Alexandre Juillerat et al. Scientific Reports
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
- (2017) Oladapo O. Yeku et al. Scientific Reports
- Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
- (2017) Xinyue Dong et al. Theranostics
- CAR T Cells Releasing IL-18 Convert to T-Bet high FoxO1 low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
- (2017) Markus Chmielewski et al. Cell Reports
- Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
- (2017) Jieming Zeng et al. Stem Cell Reports
- Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer
- (2017) Faroogh Marofi et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
- (2017) Margherita Boieri et al. OncoImmunology
- A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
- (2017) Dina Schneider et al. Journal for ImmunoTherapy of Cancer
- Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector
- (2017) Ziqing Liu et al. Scientific Reports
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes
- (2016) Laura Wayteck et al. BIOMATERIALS
- Regeneration of CD8αβ T Cells from T-cell–Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity
- (2016) Takuya Maeda et al. CANCER RESEARCH
- Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire
- (2016) David Y. Oh et al. CANCER RESEARCH
- Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
- (2016) Michael Boice et al. CELL
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
- (2016) Leonardo Morsut et al. CELL
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
- (2016) Kole T. Roybal et al. CELL
- CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
- (2016) Xiaojuan Liu et al. CELL RESEARCH
- Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
- (2016) Lisa Zimmer et al. EUROPEAN JOURNAL OF CANCER
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
- (2016) Bo Wang et al. MOLECULAR THERAPY
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
- (2016) J. Rosenblatt et al. Science Translational Medicine
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
- (2016) M Cartellieri et al. Blood Cancer Journal
- Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
- (2016) D. T. Teachey et al. Cancer Discovery
- Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
- (2016) Eloah Rabello Suarez et al. Oncotarget
- An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
- (2016) Caroline Jochems et al. Oncotarget
- Non-genetic engineering of cells for drug delivery and cell-based therapy
- (2015) Qun Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
- (2015) Mathilde Hunault-Berger et al. AMERICAN JOURNAL OF HEMATOLOGY
- Viral Vectors for Gene Therapy: Translational and Clinical Outlook
- (2015) Melissa A. Kotterman et al. Annual Review of Biomedical Engineering
- Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies
- (2015) Xuequn Ren et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
- (2015) X. Liu et al. CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Progress and challenges in viral vector manufacturing
- (2015) Johannes C.M. van der Loo et al. HUMAN MOLECULAR GENETICS
- Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity
- (2015) Maarten A. Ligtenberg et al. JOURNAL OF IMMUNOLOGY
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
- (2015) Mythili Koneru et al. Journal of Translational Medicine
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
- (2015) Kevin J Curran et al. MOLECULAR THERAPY
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
- (2015) Bonnie Huang et al. Science Translational Medicine
- Human Induced Pluripotent Stem Cell-Derived B Lymphocytes Express sIgM and Can Be Generated via a Hemogenic Endothelium Intermediate
- (2015) Anna French et al. STEM CELLS AND DEVELOPMENT
- Mesenchymal Stromal Cells Engineered to Produce IGF-I by Recombinant Adenovirus Ameliorate Liver Fibrosis in Mice
- (2015) Esteban J. Fiore et al. STEM CELLS AND DEVELOPMENT
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
- (2015) Ludovic Martinet et al. Cell Reports
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition
- (2015) Maud Condomines et al. PLoS One
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
- (2014) Claire Germain et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors
- (2014) Ikrame Amara et al. BIOCHIMIE
- CD28z CARs and Armored CARs
- (2014) Hollie J. Pegram et al. CANCER JOURNAL
- CAR T Cells for Solid Tumors
- (2014) Sunitha Kakarla et al. CANCER JOURNAL
- Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN
- (2014) A. Textor et al. CANCER RESEARCH
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- Biopolymer implants enhance the efficacy of adoptive T-cell therapy
- (2014) Sirkka B Stephan et al. NATURE BIOTECHNOLOGY
- Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
- (2014) Luciana Chessa et al. Orphanet Journal of Rare Diseases
- A Novel and Effective Cancer Immunotherapy Mouse Model Using Antigen-Specific B Cells Selected In Vitro
- (2014) Tatsuya Moutai et al. PLoS One
- GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
- (2014) Yuling Zhao et al. PLoS One
- Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
- (2014) P. R. Kumaresan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human natural killer cell development in secondary lymphoid tissues
- (2014) Aharon G. Freud et al. SEMINARS IN IMMUNOLOGY
- Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices
- (2014) Nichole M. Daringer et al. ACS Synthetic Biology
- Synthetic Microbes As Drug Delivery Systems
- (2014) Jan Claesen et al. ACS Synthetic Biology
- Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8 + T Cells
- (2013) Raul Vizcardo et al. Cell Stem Cell
- Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
- (2013) Toshinobu Nishimura et al. Cell Stem Cell
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
- (2013) Maria Themeli et al. NATURE BIOTECHNOLOGY
- Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
- (2013) A. Lutterotti et al. Science Translational Medicine
- PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
- (2013) V. D. Fedorov et al. Science Translational Medicine
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo
- (2013) E. Lanitis et al. Cancer Immunology Research
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- BDNF: The career of a multifaceted neurotrophin in spinal cord injury
- (2012) N. Weishaupt et al. EXPERIMENTAL NEUROLOGY
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- A Cell-Delivered and Cell-Activated SN38-Dextran Prodrug Increases Survival in a Murine Disseminated Pancreatic Cancer Model
- (2012) Matthew T. Basel et al. Small
- Preclinical Toxicity Evaluation of Erythrocyte-Encapsulated Thymidine Phosphorylase in BALB/c Mice and Beagle Dogs: An Enzyme-Replacement Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy
- (2012) Michelle Levene et al. TOXICOLOGICAL SCIENCES
- Functional Mechanisms for Human Tumor Suppressors
- (2012) Wanpeng Sun et al. Journal of Cancer
- Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis
- (2011) Min-Jung Park et al. ARTHRITIS AND RHEUMATISM
- Engineering Cell Surfaces via Liposome Fusion
- (2011) Debjit Dutta et al. BIOCONJUGATE CHEMISTRY
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
- (2011) Kerry S. Campbell et al. IMMUNOLOGY
- FurinDB: A Database of 20-Residue Furin Cleavage Site Motifs, Substrates and Their Associated Drugs
- (2011) Sun Tian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
- (2011) M. O. Butler et al. Science Translational Medicine
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Interleukin-10 Delivery via Mesenchymal Stem Cells: A Novel Gene Therapy Approach to Prevent Lung Ischemia–Reperfusion Injury
- (2010) Eddie Manning et al. HUMAN GENE THERAPY
- Genetically modified macrophages expressing hypoxia regulated cytochrome P450 and P450 reductase for the treatment of cancer
- (2010) Kan INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
- (2010) Matthias T Stephan et al. NATURE MEDICINE
- Regulation of human NK-cell cytokine and chemokine production by target cell recognition
- (2009) C. Fauriat et al. BLOOD
- Cell-Targeted Self-Assembled DNA Nanostructures
- (2009) Alexey Y. Koyfman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins†
- (2008) Margot G. Paulick et al. BIOCHEMISTRY
- Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes.
- (2008) X. M. Luo et al. BLOOD
- Cardiac Toxicity of ErbB2-Targeted Therapies: What Do We Know?
- (2008) Edith A. Perez Clinical Breast Cancer
- Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct
- (2008) J A Curtin et al. GENE THERAPY
- Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2
- (2008) Bianca Heemskerk et al. HUMAN GENE THERAPY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
- (2008) Angel Varela-Rohena et al. NATURE MEDICINE
- Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8+ T Cells and Regulatory T Cells
- (2008) Richard G. Carroll et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now